Table 1. Patient characteristics.
| N = 26 | (%) | |
|---|---|---|
| Gender, male/female | 19/7 | (73/27) |
| Age, median (range) | 64 | (44 - 86) |
| ECOG PS, 0/1/2 | 2/22/2 | (8/85/8) |
| Location, Upper/Middle/Lower | 9/9/8 | (35/35/31) |
| Lauren classification, Intestinal/Diffuse | 14/13 | (52/48) |
| HER2 status, +/- | 3/23 | (12/89) |
| Number of previous treatments, 1/2/≥3 | 3/11/12 | (12/42/46) |
| Previous radiotherapy, +/- | 3/23 | (12/89) |
| Liver metastasis | ||
| Yes/No | 7/19 | (27/73) |
| Ascites | ||
| Yes/No | 14/12 | (54/46) |
| Pretreatment NLR, median (range) | 2.22 | (0.94–17.4) |
| Pretreatment NLR, <5/≥5 | 20/6 | (77/23) |
| Posttreatment NLR, median (range) | 2.84 | (1.03–12.3) |
| Posttreatment NLR, <5/≥5 | 21/5 | (81/19) |
Abbreviations: ECOG PS, the Eastern Cooperative Oncology Group Performance Status; NLR, neutrophil-to-lymphocyte ratio.